September is National Ovarian Cancer Awareness Month

September is National Ovarian Cancer Awareness month and an important time to raise awareness of the most deadly gynecological cancer in the U.S.  Early signs and symptoms of ovarian cancer are often missed, leading to most ovarian cancers…

OPKO Health Receives U.S. FDA Approval for the 4Kscore® Test

MIAMI, Dec. 08, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that the U.S. Food and Drug Administration (FDA) has approved OPKO’s 4Kscore Test. This test is approved for use in men age 45 and older who have…

BioReference Laboratories Acquires U.S. Ariosa Centralized Laboratory Prenatal Testing Business

ELMWOOD PARK, N.J., August 16, 2021 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced the acquisition of the U.S. Ariosa centralized laboratory prenatal testing business from Roche. Ariosa's…

OPKO Health’s BioReference Laboratories Launches Best-in-Class Next-Generation Sequencing (NGS) Assay

,
ELMWOOD PARK, N.J., September 2, 2020 — BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), along with its specialty oncology division, GenPath, today announced the launch of OnkoSight AdvancedTM, a next-generation sequencing…

Novitas Issues Proposed Local Coverage Determination for the 4Kscore® Test

,
Proposed LCD will allow Medicare coverage within criteria for the 4Kscore® Test MIAMI, June 28, 2019 (GLOBE NEWSWIRE) — OPKO Health, Inc. (OPK) today announced that Novitas Solutions, Inc. has issued a new proposed local coverage determination…

BioReference and GenPath Support Man Cave Health During National Men’s Health Month

Complimentary PSA Testing Provided to Participants of Annual Golf Tournament ELMWOOD PARK, N.J., June 7 – BioReference Laboratories, Inc., along with its specialty oncology and urology division, GenPath, announce today their support of…

Aerobic Vaginitis (AV) Testing Now Available At BioReference and GenPath

National launch of aerobic vaginitis (AV) testing coincides with National Women’s Health Week Elmwood Park, NJ, May 17, 2019 — BioReference Laboratories, Inc., an OPKO Health company, along with its specialty women’s health division,…

BioReference and GenPath to Present at ACOG 2019, Demonstrating Commitment to the Research of Hereditary Conditions

ELMWOOD PARK, N.J., May 2, 2019 – BioReference Laboratories, Inc., an OPKO Health Company, along with its women’s health division GenPath, today announced the presentation of new research from its prenatal and hereditary cancer assessment…